Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence

World Journal of Gastroenterology

Volumn 12, Issue 18, 2006, Pages 2991-2999

  Eslick, Guy D ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Gastric cancer; Helicobacter pylori; Meta analysis; Systematic review

Indexed keywords

BACTERIAL STRAIN; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DATA ANALYSIS; DISEASE ASSOCIATION; EMBASE; EPIDEMIOLOGICAL DATA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INFECTION RISK; INFORMATION RETRIEVAL; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; NONHUMAN; PREVALENCE; REVIEW; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; SYSTEMATIC REVIEW;

EID: 33744527899     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i19.2991     Document Type: Review

References (107)

1. Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-1275
2. Warren RJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273
3. McNulty CA. The discovery of Campylobacter-like organisms. Curr Top Microbiol Immunol 1999; 241: 1-9
4. Allen P. What's the story H pylori? Lancet 2001; 357: 694
5. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61:1-241
6. Kuipers EJ, Gracia-Casanova M, Pena AS, Pals G, Van Kamp G, Kok A, Kurz-Pohlmann E, Pels NF, Meuwissen SG. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol 1993; 28: 433-437
7. Estevens J, Fidalgo P, Tendeiro T, Chagas C, Ferra A, Leitao CN, Mira FC. Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study. Eur J Cancer Prev 1993; 2: 377-380
8. Webb PM, Yu MC, Forman D, Henderson BE, Newell DG, Yuan JM, Gao YT, Ross RK. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996; 67: 603-607
9. Kim HY, Cho BD, Chang WK, Kim DJ, Kim YB, Park CK, Shin HS, Yoo JY. Helicobacter pylori infection and the risk of gastric cancer among the Korean population. J Gastroenterol Hepatol 1997; 12: 100-103
10. Crespi M, Citarda F. Helicobacter pylori and gastric cancer: an overrated risk? Scand J Gastroenterol 1996; 31: 1041-1046
11. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-648
12. Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology 2005; 128: 1579-1605
13. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965; 58: 295-300
14. Koch R. Die Aetiologie der Tuberkulose. Berl Klin Wochenschr 1882; 19: 221-230
15. Evans AS. Causation and disease: a chronological journey. The Thomas Parran Lecture. Am J Epidemiol 1978; 108: 249-258
16. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169-1179
17. Last JM. Dictionary of Epidemiology. 4th ed. UK: Oxford University Press, 2001
18. Eslick GD; Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94:2373-2379
19. Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999; 13: 851-856
20. Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, Inaba Y. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 1995; 75: 2789-2793
21. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16: 1677-1682
22. Kountouras J, Mylopoulos N, Boura P, Bessas C, Chatzopoulos D, Venizelos J, Zavos C. Relationship between Helicobacter pylori infection and glaucoma. Ophthalmology 2001; 108: 599-604
23. Gasbarrini A, Massari I, Serricchio M, Tondi P, De Luca A, Franceschi F, Ojetti V, Dal Lago A, Flore R, Santoliquido A, Gasbarrini G, Pola P. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 1998; 43: 1641-1645
24. Monstein HJ, Jonsson Y, Zdolsek J, Svanvik J. Identification of Helicobacter pylori DNA in human cholesterol gallstones. Scand J Gastroenterol 2002; 37: 112-119
25. Tunca A, Turkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A case-control study. Acta Neurol Belg 2004; 104: 161-164
26. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96: 1039-1046
27. Aceti A, Are R, Sabino G, Fenu L, Pasquazzi C, Quaranta G, Zechini B, Terrosu P. Helicobacter pylori active infection in patients with acute coronary heart disease. J Infect 2004; 49: 8-12
28. El Miedany YM, Baddour M, Ahmed I, Fahrny H. Sjogren's syndrome: concomitant H pylori infection and possible correlation with clinical parameters. Joint Bone Spine 2005; 72: 135-141
29. Reinauer S, Megahed M, Goerz G, Ruzicka T, Borchard F, Susanto F, Reinauer H. Schonlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 1995; 33: 876-879
30. Tomasi PA, Dore MP, Fanciulli G, Sanciu F, Realdi G, Delitala G, Is there anything to the reported association between Helicobacter pylori infection and autoinumme thyroiditis? Dig Dis Sci 2005; 50: 385-388
31. Caselli M, Zaffoni E, Ruina M, Sartori S, Trevisani L, Ciaccia A, Alvisi V, Fabbri L, Papi A. Helicobacter pylori and chronic bronchitis. Scand J Gastroenterol 1999; 34: 828-830
32. Pierantozzi M, Pietroiusti A, Galante A, Sancesario G, Lunardi G, Fedele E, Giacomini P, Stanzione P. Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients. Ann Neurol 2001; 50: 686-687
33. Altschuler A. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischernic neuropathy. Med Hypotheses 1996; 47: 413-414
34. Gasbarrini A, Franceschi F. Does H pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoinimune diseases? Am J Gastroenterol 2005; 100: 1271-1273
35. Gedik GK, Karaduman A, Sivri B, Caner B. Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms? J Eur Acad Dermatol Venereol 2005; 19: 398-399
36. Rigopoulos D, Katsambas A, Karalexis A, Papatheodorou G, Rokkas T. No increased prevalence of Helicobacter pylori in patients with alopecia areata. J Am Acad Dermatol 2002; 46: 141
37. Yang YJ, Sheu BS, Lee SC, Yang HB, Wu JJ. Children of Helicobacter pylori-infected dyspeptic mothers are predisposed to H pylori acquisition with subsequent iron deficiency and growth retardation. Helicobacter 2005; 10: 249-255
38. Richter T, Richter T, List S, Muller DM, Deutscher J, Uhlig HH, Krumbiegel P, Herbarth O, Gutsmuths FJ, Kiess W. Five- to 7-year-old children with Helicobacter pylori infection are smaller than Helicobacter-negative children: a cross-sectional population-based study of 3,315 children. J Pediatr Gastroenterol Nutr 2001; 33:472-475
39. Bravo LE, Mera R, Reina JC, Pradilla A, Alzate A, Fontham E, Correa P. Impact of Helicobacter pylori infection on growth of children: a prospective cohort study. J Pediatr Gastroenterol Nutr 2003; 37: 614-619
40. Rosenstock SJ, Jorgensen T, Andersen LP, Bonnevie O. Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health 2000; 28: 32-40
41. Zullo A, Hassan C, Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol 2003; 37: 164-168
42. Cremonini F, Gabrielli M, Gasbarrini G, Pola P, Gasbarrini A. The relationship between chronic H pylori infection, CagA seropositivity and stroke: meta-analysis. Atherosclerosis 2004; 173: 253-259
43. Gasbarrini A, Carloni E, Gasbarrini G, Chisholm SA. Helicobacter pylori and extragastric diseases-other Helicobacters. Helicobacter 2004; 9 Suppl. 1: 57-66
44. Strachan DP. Non-gastrointestinal consequences of Helicobacter pylori infection. Br Med Bull 1998; 54: 87-93
45. Patal P, Gasbarrini G, Pretolani S, Gasbarrini A, Franceschi F. Extradigestive diseases and Helicobacter pylori infection. Curr Opin Gastroenterol 1997; 13: 52-55
46. Leontiadis GI, Sharma VK, Howden CW. Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 1999; 159: 925-940
47. Realdi G, Dore MP, Fastame L. Extradigestive manifestations of Helicobacter pylori infection: fact and fiction. Dig Dis Sci 1999; 44: 229-236
48. Israel DA, Peek RM. pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther 2001; 15: 1271-1290
49. Baldari CT, Lanzavecchia A, Telford JL. Immune subversion by Helicobacter pylori. Trends Immunol 2005; 26: 199-207
50. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005; 128:1567-1578
51. Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology 1997; 113: S51-S55
52. Ernst FB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000; 54: 615-640
53. Mitchell HM, Bohane TD, Tobias V, Bullpitt P, Daskalopoulos G, Carrick J, Mitchell JD, Lee A. Helicobacter pylori infection in children: potential clues to pathogenesis. J Pediatr Gastroenterol Nutr 1993; 16: 120-125
54. Eslick GD. Pregnant women and the Helicobacter pylori generation effect. Helicobacter 2003; 8: 643
55. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219-221
56. Harvey RF, Spence RW, Lane JA, Nair P, Murray LJ, Harvey IM, Donovan J. Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal uker. QJM 2002; 95: 519-525
57. Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, Vandenbroucke-Grauls CM. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997; 92: 1480-1482
58. Veldhuyzen van Zanten SJ, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis 1994; 169: 434-437
59. Camargo MC, Yepez MC, Ceron C, Guerrero N, Bravo LE, Correa P, Fontham ET. Age at acquisition of Helicobacter pylori infection: comparison of two areas with contrasting risk of gastric cancer. Helicobacter 2004; 9: 262-270
60. Xia HH, Talley NJ. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol 1997; 92: 1780-1787
61. Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 2005; 100: 2083-2099
62. Virchow R. Cellular Pathology. London, John Churchill, 1860
63. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539-545
64. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-285
65. Moss SF, Blaser MJ. Mechanisms of disease: Inflammation and the origins of cancer. Nat Clin Pract Oncol 2005; 2: 90-97; quiz 1 p following 113
66. Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997; 6: 387-400
67. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 15: 702-703
68. M'Fadyan J, Hobday F. Note on the experimental "transmission of warts in the dog". J Comp Pathol Ther 1898; 11: 341-343
69. Ferri C, La Civita L, Zignego AL, Pasero G. Viruses and cancers: possible role of hepatitis C virus. Eur J Clin Invest 1997; 27: 711-718
70. Kew MC. The hepatitis B virus and the genesis of hepatocellular carcinoma. GI Cancer 1996; 1: 143-148
71. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869
72. Welton JC, Marr JS, Friedman SM. Association between hepatobiliary cancer and typhoid carrier state. Lancet 1979; 1: 791-794
73. Ferguson AR. Associated bilharziasis and primary malignant disease of the urinary bladder, with observations in a series of forty cases. J Path Bacteriol 1911; 16: 76-94
74. Yamaguchi N, Kakizoe T. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncol 2001; 2: 88-94
75. Xia HH, Wong BC. Nitric oxide in Helicobacter pylori-induced apoptosis and its significance in gastric carcinogenesis. J Gastroenterol Hepatol 2003; 18: 1227-1230
76. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003; 3: 592-600
77. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37
78. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001; 96: 16-26
79. Tajima K. Challenging epidemiological strategy for paradoxical evidence on the risk of gastric cancer from Helicobacter pylori infection. Jpn J Clin Oncol 2002; 32: 275-276
80. GLOBOCAN 2002. International Agency for Research on Cancer (IARC), Lyon France. (http://www-dep.iarc.fr/)
81. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 2003; 106: 953-960
82. Louw JA, Kidd MS, Kummer AF, Taylor K, Kotze U, Hanslo D. The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter 2001; 6: 268-273
83. Masci E, Viale E, Freschi M, Porcellati M, Tittobello A. Precancerous gastric lesions and Helicobacter pylori. Hepatogastroenterology 1996; 43: 854-858
84. Genta RM, Gurer IE, Graham DY, Krishnan B, Segura AM, Gutierrez O, Kim JG, Burchette JL Jr. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 1996; 111: 1206-1211
85. Osawa H, Inoue F, Yoshida Y. Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia. J Clin Pathol 1996; 49: 112-115
86. Shimizu N, Ikehara Y, Inada K, Nakanishi H, Tsukamoto T, Nozaki K, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu. M. Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 2000; 60: 1512-1514
87. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194
88. Parsonnet J, Forman D. Helicobacter pylori infection and gastric cancer-for want of more outcomes. JAMA 2004; 291: 244-245
89. Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005; 21:1121-1126
90. Dixon MF. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001; 49: 2-4
91. Genta RM. Screening for gastric cancer: does it make sense? Aliment Pharmacol Ther 2004; 20 Suppl 2: 42-47
92. Mc Loughlin RM, Sebastian SS, O'Connor HJ, Buckley M, O'Morain CA. Review article: test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention? Aliment Pharmacol Ther 2003; 17 Suppl 2: 82-88
93. Xue FB, Xu YY, Wan Y, Pan BR, Ren J, Fan DM. Association of H pylori infection with gastric carcinoma: a Meta analysis. World J Gastroenterol 2001; 7: 801-804
94. Axon A. Review article: gastric cancer and Helicobacter pylori. Aliment Pharmacol Ther 2002; 16 Suppl 4: 83-88
95. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125: 1636-1644
96. Forman D. Helicobacter pylori infection and gastric carcinogenesis. Eur J Gastroenterol Hepatol 1992; 4 suppl 2: S31-S35
97. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M. Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999; 20: 669-676
98. Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 1998; 58: 2067-2069
99. Tokieda M, Honda S, Fujioka T, Nasu M. Effect of Helicobacter pylori infection on the N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in mongolian gerbils. Carcinogenesis 1999; 20: 1261-1266
100. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu. M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-4259
101. Hirayama F, Takagi S, Iwao E, Yokoyama Y, Haga K, Hanada S. Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 1999; 34: 450-454
102. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436-439
103. Marshall BJ, McGechie DB, Rogers PA, Glancy RJ. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142:439-444
104. Wang TC, Fox JG. Helicobacter pylori and gastric cancer: Koch's postulates fulfilled? Gastroenterology 1998; 115: 780-783
105. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-1739
106. Wang JT, Chang CS, Lee CZ, Yang JC, Lin JT, Wang TH. Antibody to a Helicobacter pylori species specific antigen in patients with adenocarcinoma of the stomach. Biochem Biophys Res Commun 1998; 244: 360-363
107. Janulaityte-Gunther D, Kupcinskas L, Pavilonis A, Valuckas K, Percival Andersen L, Wadstrom T. Helicobacter pylori antibodies and gastric cancer: a gender-related difference. FEMS Immunol Med Microbiol 2005; 44: 191-195